Truist I think will take over Pfizer as the most dormant stock with no gains after the buyback boost goes away. The long term strategy just isn’t good.
There are no replies in this thread yet. Be the first to post a reply below:
Truist I think will take over Pfizer as the most dormant stock with no gains after the buyback boost goes away. The long term strategy just isn’t good.
There are no replies in this thread yet. Be the first to post a reply below: